ZLAB

Zai Lab Limited

17.00

0.57+3.47%

After Hours: 17.35 +0.35 +2.06%19:55 02/04 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE16.60/16.43

TODAY RANGE16.57-17.14

VOL1.61M

MARKET CAP1.88B

52 WEEK RANGE15.96-44.34

AVG VOL (3M)881.08K

% TURNOVER1.45%

TURNOVER--

P/E (TTM)-8.7503

% RANGE3.26%

EPS(TTM)-1.9428

P/E(FORWARD)-10.8280

P/B2.474

BVPS6.87

DIVIDEND--

P/S4.592

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.82B

SHARES OUTSTANDING110.59M

NEXT EARNINGS02/25-03/02

FREE FLOAT106.96M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·12h ago
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
TipRanks·2d ago
SPDB Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TipRanks·6d ago
Zai Lab Ltd (1ZLB) Gets a Buy from Guotai Haitong
TipRanks·01/15 13:07
Goldman Sachs Remains a Buy on Zai Lab Ltd (1ZLB)
TipRanks·01/15 12:25
Zai Lab (ZLAB) Receives a Buy from Goldman Sachs
TipRanks·01/15 11:36
Citi Keeps Their Buy Rating on Zai Lab (ZLAB)
Seeking Alpha·01/14 19:33
Grail and Indivior PLC come out on top in Healthcare quant picks ahead of Q4 earnings
Reuters·01/13 13:02
Zai Lab Announces 2026 Strategic Plan Focused on Advancing Global Pipeline, Launching New Products, and Expanding Clinical Development Programs
Reuters·01/13 13:00
ZAI LAB HIGHLIGHTS STRATEGIC PRIORITIES AND GLOBAL PIPELINE PROGRESS AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Reuters·01/12 12:02
Novocure Reports Record 2025 Revenue with 8% Annual Growth
Dow Jones·01/07 20:25
Zai Lab Price Target Announced at $35.00/Share by UBS
TipRanks·01/07 13:21
Zai Lab initiated with a Buy at UBS
TipRanks·01/06 12:35
Zai Lab announces China NMPA approval for Augtryo sNDA
Reuters·01/06 12:30
China Approves Zai Lab's AUGTYRO for NTRK-Positive Solid Tumors
Reuters·01/06 12:30
ZAI LAB ANNOUNCES NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) APPROVAL OF AUGTYRO™ (REPOTRECTINIB) FOR PATIENTS WITH NTRK-POSITIVE SOLID TUMORS

Same Industry

Name/Symbol

Change%

Price

Zai Lab Limited

ZLAB

+3.47%

17.00

McKesson

MCK

-3.42%

822.00

Biogen Inc

BIIB

+4.92%

185.45

Amgen Inc

AMGN

+8.15%

366.20

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+26.36%

0.0949

Celgene

CELG

108.24

Lilly Eli & Co

LLY

+10.33%

Therapeuticsmd Inc

TXMD

-3.43%

2.25

Johnson & Johnson

JNJ

+0.59%

234.47

Abbvie Inc

ABBV

-3.79%

217.11

Zoetis Inc

ZTS

+3.50%

126.70

Gilead Sciences Inc

GILD

+2.06%

146.23

Novo-Nordisk A/S

NVO

-6.18%

47.19

Bristol-Myers Squibb Co

BMY

+2.91%

57.62

Pfizer

PFE

+3.92%

26.78

Alexion Pharms

ALXN

+1.70%

182.50

Sanofi FR

SNY

+1.24%

48.08

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+2.04%

152.91

Dr Reddys Labs

RDY

+1.38%

14.00

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.